HOME >> MEDICINE >> NEWS
Chemotherapy with bevacizumab increases risk of blood clots in arteries

Treatment with chemotherapy and bevacizumab, an anticancer drug, is associated with a greater risk of blood clots in patients arteries compared with treatment with chemotherapy only, according to a study published online August 7 in the Journal of the National Cancer Institute.

The combination of chemotherapy and bevacizumab has been shown to increase survival in patients with metastatic colorectal and nonsmall-cell lung cancer, but some previous studies suggest these patients are at an increased risk for blood clots in their arteries.

Frank Scappaticci, M.D., Ph.D., of Genentech, Inc. in South San Francisco, Calif., and colleagues analyzed data from five randomized controlled trials that included 1,745 patients with metastatic colorectal, breast, or nonsmall-cell lung cancer.

Among patients treated with the combination therapy, 3.8 percent experienced blood clots in their arteries, compared with 1.7 percent of patients on chemotherapy alone. There was no statistically significant difference in the incidence of blood clots in veins. Risk factors for blood clots in both arteries and veins included previous blood clots and older age (65 or older.)

The clinical benefit associated with bevacizumab therapy was maintained for all subgroups. Although death from [a blood clot in the artery] was uncommon, we did not capture functional disabilities from these events, and the risk factorsidentified in this study should be considered when making treatment decisions for individual patients, the authors write.


'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
7-Aug-2007


Page: 1

Related medicine news :

1. Chemotherapy may enhance the effectiveness of brain tumor vaccines
2. Chemotherapy more effective when given before breast cancer surgery
3. Chemotherapy temporarily affects the structures of the human brain
4. Chemotherapy gel may fight breast cancer and reduce breast deformity
5. Chemotherapy given directly to the liver improves survival for patients with colorectal cancer
6. Chemotherapy after surgery extends survival for patients with advanced endometrial cancer
7. Chemotherapy errors rare, but have potential for serious consequences
8. Chemotherapy for brain tumors is boosted after vaccine targets resistance-related antigen
9. Chemotherapy options improve for patients with advanced colorectal cancer
10. Reduced greenhouse gas emissions required to avoid dangerous increases in heat stress
11. Risk of Parkinsons disease increases with pesticide exposure and head trauma

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... Calif. (PRWEB) , ... September ... ... Imaging Society (WMIS) showcased several first-in-human studies on the detection and treatment ... Highlighting two examples of these ground-breaking studies were noninvasive detection of residual ...
(Date:9/11/2019)... ... September 11, 2019 , ... Workplace injuries cost individuals, ... solve injury risks which lead to musculoskeletal disorders (MSDs). , Starting with ... the team at Soter Analytics helps avoid ergonomic injury by coaching ...
(Date:9/11/2019)... ... September 11, 2019 , ... GRM Information ... AHIMA Health Data and Information Conference in Chicago, Illinois September 14 to 18. ... learn more about GRM’s healthcare information management solutions . , Built around ...
(Date:9/11/2019)... ... 2019 , ... Ahipoki is excited to announce a new vegan and gluten ... vegetarians, pescatarians and poke bowl fans alike. Ahimi is made of five simple ... texture similar to tuna, Ahipoki customers will now have a vegan option ...
(Date:9/11/2019)... ... 10, 2019 , ... Four Shriners for Children Medical Center ... recognized among the best doctors in the San Gabriel Valley for providing high-quality, ... H. Cho, M.D. – Chief of Staff, scoliosis, spinal deformity surgery, limb deformity, ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... BOSTON (PRWEB) , ... September 13, 2019 , ... ... provider of teledentistry services for employers, became the first commercial teledentistry practice in ... an award-winning startup with other hub entrepreneurs, company leaders, innovators and industry experts ...
(Date:9/14/2019)... ... ... The Allergenic Products Advisory Committee of the Food and Drug Administration (FDA) ... approval of a standardized oral immunotherapy (OIT) product for peanut allergy. The brand name ... The FDA would require a Risk Evaluation and Mitigation Strategy (REMS) to be developed ...
(Date:9/12/2019)... ... ... Stratosphere Networks will sponsor GRIN2B Foundation’s first cocktail reception fundraiser, Gather ... Kitchen and Social House in Evanston from 6 p.m. to 9 p.m. , Proceeds ... gene on the short arm of the 12th chromosome and is part of a ...
Breaking Medicine Technology:
Cached News: